טוען...
Correlations between atazanavir C(trough )and hyperbilirubinemia: a case report
INTRODUCTION: Hyperbilirubinemia is a common side effect of the antiretroviral agent atazanavir but is generally reversible upon discontinuation of treatment. We used therapeutic drug monitoring to investigate the occurrence of hyperbilirubinemia in a 49-year-old Hispanic man infected with HIV, foll...
שמור ב:
Main Authors: | , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
BioMed Central
2009
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2803830/ https://ncbi.nlm.nih.gov/pubmed/20062736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-3-9307 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|